Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- ALAIN DUPUY
HOPITAL PONTCHAILLOU - RENNES CEDEX 9
Principal Investigator - ANNICK BARBAUD
HOPITAUX DE BRABOIS - VANDOEUVRE LES NANCY CEDEX
Principal Investigator - BRIGITTE MILPIED
HOPITAL ST ANDRE - BORDEAUX CEDEX
Principal Investigator - CHRISTOPHE BEDANE
HOPITAL DUPUYTREN - LIMOGES CEDEX 1
Principal Investigator - CLAIRE BERNIER TAUGOURDEAU
HOPITAL HOTEL DIEU - NANTES CEDEX 1
Principal Investigator - DELPHINE STAUMONT SALLE
HOPITAL CLAUDE HURIEZ- LILLE CEDEX
Principal Investigator - EMMANUEL MAHE
CH VICTOR DUPOUY - ARGENTEUIL CEDEX
Principal Investigator - EMMANUELLE AMSLER
HOPITAL TENON - PARIS CEDEX 20
Principal Investigator - EVELYNE COLLET
CHU SITE DU BOCAGE - DIJON CEDEX
Principal Investigator - FABIEN PELLETIER
HOPITAL JEAN MINJOZ - BESANCON CEDEX
Principal Investigator - FRANCOISE GIORDANO LABADIE
HOPITAL LARREY - TOULOUSE CEDEX 9
Principal Investigator - FREDERIC CAMBAZARD
CHU SAINT ETIENNE - ST PRIEST EN JAREZ CEDEX
Principal Investigator - GERARD GUILLET
CHR LA MILETRIE - POITIERS CEDEX
Principal Investigator - GERMAINE GABISON
HOPITAL SAINT LOUIS - PARIS CEDEX 10
Principal Investigator - JEAN-JACQUES GROB
HOPITAL TIMONE - MARSEILLE CEDEX 05
Principal Investigator - JEAN-PHILIPPE LACOUR
HOPITAL DE L'ARCHET - NICE CEDEX 3
Principal Investigator - JULIETTE JEGOU
CH DE CHALONS EN CHAMPAGNE - CHALONS EN CHAMPAGNE CEDEX
Principal Investigator - LAURENCE BOUILLET
CHU DE GRENOBLE - LA TRONCHE
Principal Investigator - LAURENT MEUNIER
HOPITAL CAREMEAU - NIMES CEDEX 9
Principal Investigator - LILIANE LAROCHE
HOPITAL AVICENNE - BOBIGNY CEDEX
Principal Investigator - LUDOVIC MARTIN
HOTEL DIEU - ANGERS CEDEX 9
Principal Investigator - MARIE CHRISTINE FERRIER LE BOUEDEC
CHU ESTAING - CLERMONT FERRAND
Principal Investigator - MARIE SYLVIE DOUTRE
HOPITAL DE HAUT LEVEQUE - PESSAC CEDEX
Principal Investigator - NADIA RAISON PEYRON
HOPITAL ST ELOI - MONTPELLIER CEDEX 5
Principal Investigator - OLIVIER CHOSIDOW
HOPITAL HENRI MONDOR - CRETEIL
Principal Investigator - PASCAL JOLY
HOPITAL CHARLES NICOLLE - ROUEN CEDEX
Principal Investigator - PATRICE PLANTIN
CHI DE CORNOUAILLE - QUIMPER CEDEX
Principal Investigator - PHILIPPE BERBIS
HOPITAL NORD- MARSEILLE
Principal Investigator - PHILIPPE MODIANO
HOPITAL ST VINCENT DE PAUL - LILLE CEDEX
Principal Investigator - SELIM ARACTINGI
HOPITAL COCHIN - PARIS
Principal Investigator - THIERRY BOYE
HIA SAINTE ANNE - TOULON CEDEX 9
Principal Investigator - VINCENT DESCAMPS
HOPITAL BICHAT CLAUDE BERNARD - PARIS CEDEX 18
Principal Investigator - ZIAD REGUIAI
HOPITAL ROBERT DEBRE - REIMS CEDEX
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Novartis Investigative Site
Paris, Cedex 10, France
- Novartis Investigative Site
Limoges, Haute Vienne, France
- Novartis Investigative Site
Toulon, Val De Marne, France
- Novartis Investigative Site
Angers, France
- Novartis Investigative Site
Argenteuil, France
- Novartis Investigative Site
Besançon, France
- Novartis Investigative Site
Bobigny, France
- Novartis Investigative Site
Bordeaux, France
- Novartis Investigative Site
Châlons-en-Champagne, France
- Novartis Investigative Site
Clermont-Ferrand, France
- Novartis Investigative Site
Dijon, France
- Novartis Investigative Site
Grenoble, France
- Novartis Investigative Site
Lille, France
- Novartis Investigative Site
Lille, France
- Novartis Investigative Site
Lyon, France
- Novartis Investigative Site
Marseille, France
- Novartis Investigative Site
Montpellier, France
- Novartis Investigative Site
Nantes, France
- Novartis Investigative Site
Nice, France
- Novartis Investigative Site
Nîmes, France
- Novartis Investigative Site
Paris, France
- Novartis Investigative Site
Paris, France
- Novartis Investigative Site
Quimper, France
- Novartis Investigative Site
Reims, France
- Novartis Investigative Site
Rennes, France
- Novartis Investigative Site
Rouen, France
- Novartis Investigative Site
Saint-Etienne, France
- Novartis Investigative Site
Toulouse, France
- Novartis Investigative Site
Vandœuvre-lès-Nancy, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Apr 2015
- Primary completion
- 11 Jan 2016
- Completion
- 11 Jan 2016
- Last update posted
- 25 Feb 2020
- Registered enrollment
- 136
- Registry id
- NCT02550106
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.